NCPDP held its first EDvocacy Tour of 2018 last week. Members of NCPDP’s Board of Trustees, Strategic Planning Committee and Public Policy staff met with a total of 10 Congressional members, their staff and key committee staff in addition to key stakeholder groups.
The purpose of the tour was to educate policymakers about the NCPDP Standards-based Facilitator Model for PDMP, An Interoperable Framework for Patient Safety.
The EDvocacy tour was timely as the House Energy and Commerce Committee held three hearings last week focusing on opioid abuse and strategies for prevention and treatment. Earlier in the week, the White House released its Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand, which calls for a “transition to a nationally interoperable Prescription Drug Monitoring Program network.” NCPDP believes this aligns with our strategic initiative for our standards-based model.